JP2003508434A - イブプロフェン含有ソフトゲル - Google Patents

イブプロフェン含有ソフトゲル

Info

Publication number
JP2003508434A
JP2003508434A JP2001519902A JP2001519902A JP2003508434A JP 2003508434 A JP2003508434 A JP 2003508434A JP 2001519902 A JP2001519902 A JP 2001519902A JP 2001519902 A JP2001519902 A JP 2001519902A JP 2003508434 A JP2003508434 A JP 2003508434A
Authority
JP
Japan
Prior art keywords
weight
ibuprofen
soft gel
softgel
average molecular
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2001519902A
Other languages
English (en)
Japanese (ja)
Other versions
JP2003508434A5 (enExample
Inventor
ランプルナ， プラサド グラパリ，
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Patheon Softgels Inc
Original Assignee
Banner Pharmacaps Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=23536433&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=JP2003508434(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Banner Pharmacaps Inc filed Critical Banner Pharmacaps Inc
Publication of JP2003508434A publication Critical patent/JP2003508434A/ja
Publication of JP2003508434A5 publication Critical patent/JP2003508434A5/ja
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4866—Organic macromolecular compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
JP2001519902A 1999-09-02 2000-09-01 イブプロフェン含有ソフトゲル Pending JP2003508434A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US09/389,003 1999-09-02
US09/389,003 US6251426B1 (en) 1999-09-02 1999-09-02 Ibuprofen-containing softgels
PCT/US2000/023908 WO2001015688A1 (en) 1999-09-02 2000-09-01 Ibuprofen-containing softgels

Publications (2)

Publication Number Publication Date
JP2003508434A true JP2003508434A (ja) 2003-03-04
JP2003508434A5 JP2003508434A5 (enExample) 2007-10-18

Family

ID=23536433

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2001519902A Pending JP2003508434A (ja) 1999-09-02 2000-09-01 イブプロフェン含有ソフトゲル

Country Status (9)

Country Link
US (1) US6251426B1 (enExample)
EP (1) EP1207872B1 (enExample)
JP (1) JP2003508434A (enExample)
AT (1) ATE357229T1 (enExample)
AU (1) AU780212B2 (enExample)
CA (1) CA2382292C (enExample)
DE (1) DE60034044T2 (enExample)
PL (1) PL362850A1 (enExample)
WO (1) WO2001015688A1 (enExample)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2007536257A (ja) * 2004-05-06 2007-12-13 ザ プロクター アンド ギャンブル カンパニー 濃縮有効成分を含むソフトゲル封入医薬組成物
JP2009513669A (ja) * 2005-10-26 2009-04-02 バナー ファーマキャプス， インコーポレイテッド 親水性ベヒクルに基づく二重制御された放出マトリクスシステム
KR20160078216A (ko) 2014-12-24 2016-07-04 라이온 가부시키가이샤 고형 의약 조성물 및 그 제조 방법

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20020177626A1 (en) * 2001-01-19 2002-11-28 Cook Graham D. Treatment of sleep disturbances
GB0119480D0 (en) 2001-08-09 2001-10-03 Jagotec Ag Novel compositions
US6551615B1 (en) * 2001-10-18 2003-04-22 M/S. Strides Arcolab Limited Dexibuprofen-containing soft gelatin capsules and process for preparing the same
ES2302926T5 (es) * 2002-04-25 2012-08-23 Banner Pharmacaps, Inc. Cápsula blanda masticable
US20030232097A1 (en) * 2002-06-17 2003-12-18 Strides Inc. Oily wax matrix suspension formulation comprising ibuprofen free acid and potassium salt of ibuprofen
CA2498207C (en) * 2002-09-11 2012-03-13 Elan Pharma International Ltd. Gel-stabilized nanoparticulate active agent compositions
KR20040106915A (ko) * 2003-06-05 2004-12-20 한국유나이티드제약 주식회사 가용성 이부프로펜의 연질캅셀제 조성물 및 그의 제조방법
USD530814S1 (en) 2003-09-16 2006-10-24 Novartis Ag Combined capsule and tablets
USD520635S1 (en) 2003-09-16 2006-05-09 Novartis Ag Combine capsule and tablets
US20050137262A1 (en) * 2003-12-22 2005-06-23 Hu Patrick C. Highly concentrated pourable aqueous solutions of potassium ibuprofen, their preparation and their uses
CA2554243A1 (en) * 2004-01-20 2005-08-11 Stiefel Laboratories, Inc. Dermatologic soft gel compositions
CA2570649A1 (en) * 2004-06-07 2005-12-22 Strides Arcolab Limited Pharmaceutical composition containing a stable and clear solution of anti-inflammatory drug in soft gelatin capsule and process for producing the same
US20070053868A1 (en) 2005-03-08 2007-03-08 Banner Pharmacaps, Inc. Solvent system for enhancing the solubility of pharmaceutical agents
US20060240051A1 (en) * 2005-04-26 2006-10-26 Singleton Andy H Eutectic blends containing a water soluble vitamin derivative
JP5406529B2 (ja) * 2005-10-26 2014-02-05 バナー ファーマキャプス， インコーポレイテッド カプセル充墳物としての親油性ベヒクルに基づく二重制御された放出マトリクスシステム
US20090004231A1 (en) 2007-06-30 2009-01-01 Popp Shane M Pharmaceutical dosage forms fabricated with nanomaterials for quality monitoring
US8497303B2 (en) * 2008-01-18 2013-07-30 Dow Global Technologies Llc Method to enhance aqueous solubility of poorly soluble actives
US20090214648A1 (en) * 2008-02-15 2009-08-27 Malathi Kandakatla Pharmaceutical formulations comprising ibuprofen and diphenhydramine
ES2363964B1 (es) 2009-11-20 2012-08-22 Gp Pharm, S.A. Cápsulas de principios activos farmacéuticos y ésteres de ácidos grasos poliinsaturados.
DE102010063609A1 (de) 2010-12-20 2012-06-21 Awd.Pharma Gmbh & Co. Kg Neue Multikomponentenkristalle aus ([2-Amino-6-(4-fluoro-benzylamino)-pyridin-3yl)-carbamidsäureethylester und einer Arylpropionsäure
MX364440B (es) * 2013-03-15 2019-04-26 Warner Chilcott Co Llc Forma de dosis farmacéutica de cápsula de gelatina blanda con goma guar modificada.
EP3053598A1 (en) 2015-02-06 2016-08-10 Faes Farma, S.A. Calcifediol soft capsules
GB2595301B (en) * 2020-05-21 2025-01-08 Reckitt Benckiser Health Ltd Novel Formulation
WO2025150072A1 (en) * 2024-01-13 2025-07-17 Pulse Pharmaceuticals Pvt Ltd A stable oral pro-dispersion formulation and implementations thereof

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS61158921A (ja) * 1984-10-13 1986-07-18 ドロルギ−ト・ゲゼルシヤフト・ミツト・ベシユレンクテル・ハフツング・ウント・コンパニ−・コマンデツト・ゲゼルシヤフト イブプロフエン含有ゼラチン軟カプセルおよびその製造方法
WO1997003655A1 (en) * 1995-07-20 1997-02-06 Pharmacia & Upjohn Company Stable clear solutions of non-steroidal anti-inflammatory drugs for incorporation into gelatin capsules

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8305693D0 (en) * 1983-03-02 1983-04-07 Scherer Ltd R P Pharmaceutical compositions
DE3307353C2 (de) * 1983-03-02 1985-01-31 R.P. Scherer GmbH, 6930 Eberbach Polyethylenglykolhaltige Weichgelatinekapsel und Verfahren zu ihrer Herstellung
US5071643A (en) * 1986-10-17 1991-12-10 R. P. Scherer Corporation Solvent system enhancing the solubility of pharmaceuticals for encapsulation
US4900775A (en) 1988-02-29 1990-02-13 Gaf Chemicals Corporation Solubilization of complexes of water-insoluble organic compounds by aqueous solutions of polyvinylpyrrolidone
US5141961A (en) * 1991-06-27 1992-08-25 Richrdson-Vicks Inc. Process for solubilizing difficulty soluble pharmaceutical actives
US5376688A (en) 1992-12-18 1994-12-27 R. P. Scherer Corporation Enhanced solubility pharmaceutical solutions
US5431916A (en) 1993-04-29 1995-07-11 The Procter & Gamble Company Pharmaceutical compositions and process of manufacture thereof
JPH08509725A (ja) 1993-04-30 1996-10-15 ザ、プロクター、エンド、ギャンブル、カンパニー コートされた医薬組成物
IT1264855B1 (it) 1993-06-21 1996-10-17 Zambon Spa Composizioni farmaceutiche contenenti sali dell'acido s(+)-2-(4-isobutilfenil) propionico con amminoacidi basici
CA2181241C (en) 1994-01-24 2000-04-25 Dadi Jamshed Dhabhar Process for solubilizing difficultly soluble pharmaceutical actives
US5484606A (en) 1994-01-24 1996-01-16 The Procter & Gamble Company Process for reducing the precipitation of difficulty soluble pharmaceutical actives
US5538737A (en) 1994-11-30 1996-07-23 Applied Analytical Industries, Inc. Oral compositions of H2 -antagonists
US5468502A (en) 1994-12-20 1995-11-21 American Home Products Corporation Ibuprofen enhancing solvent system
US5660859A (en) 1994-12-29 1997-08-26 Mcneil-Ppc, Inc. Gelling agent for polyethylene glycol
US5641512A (en) 1995-03-29 1997-06-24 The Procter & Gamble Company Soft gelatin capsule compositions
US6221391B1 (en) 1998-11-23 2001-04-24 Accucaps Industries Limited Self-emulsifying ibuprofen solution and soft gelatin capsule for use therewith

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS61158921A (ja) * 1984-10-13 1986-07-18 ドロルギ−ト・ゲゼルシヤフト・ミツト・ベシユレンクテル・ハフツング・ウント・コンパニ−・コマンデツト・ゲゼルシヤフト イブプロフエン含有ゼラチン軟カプセルおよびその製造方法
WO1997003655A1 (en) * 1995-07-20 1997-02-06 Pharmacia & Upjohn Company Stable clear solutions of non-steroidal anti-inflammatory drugs for incorporation into gelatin capsules

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2007536257A (ja) * 2004-05-06 2007-12-13 ザ プロクター アンド ギャンブル カンパニー 濃縮有効成分を含むソフトゲル封入医薬組成物
JP2009513669A (ja) * 2005-10-26 2009-04-02 バナー ファーマキャプス， インコーポレイテッド 親水性ベヒクルに基づく二重制御された放出マトリクスシステム
JP2013216680A (ja) * 2005-10-26 2013-10-24 Banner Pharmacaps Inc 親水性ベヒクルに基づく二重制御された放出マトリクスシステム
KR20160078216A (ko) 2014-12-24 2016-07-04 라이온 가부시키가이샤 고형 의약 조성물 및 그 제조 방법

Also Published As

Publication number Publication date
AU780212B2 (en) 2005-03-10
AU7094900A (en) 2001-03-26
WO2001015688A1 (en) 2001-03-08
PL362850A1 (pl) 2004-11-02
DE60034044D1 (de) 2007-05-03
CA2382292C (en) 2008-02-26
ATE357229T1 (de) 2007-04-15
EP1207872B1 (en) 2007-03-21
US6251426B1 (en) 2001-06-26
CA2382292A1 (en) 2001-03-08
EP1207872A1 (en) 2002-05-29
DE60034044T2 (de) 2007-12-06

Similar Documents

Publication Publication Date Title
JP2003508434A (ja) イブプロフェン含有ソフトゲル
KR100341522B1 (ko) 고농축아세트아미노펜용액을함유하는젤라틴캡슐
US5431916A (en) Pharmaceutical compositions and process of manufacture thereof
US20110086844A1 (en) Oral Solid Solution Formulation of a Poorly Water-Soluble Active Substance
US20110020440A1 (en) Stable solutions of sparingly soluble actives
WO1995031979A1 (en) Solutions of aryl or heteroaryl substituted alkanoic acids in lipophilic solvents and soft gelatin capsules containing such solutions
US20020164369A1 (en) Novel soft-gelatin capsule comprising S-adenosylmethionine and a method for producing the same
KR100679582B1 (ko) 경질 쉘 캡슐용 이부프로펜 용액
US7063864B1 (en) Morphine sulphate microgranules, method for preparing same and compositions containing same
WO2006047068A1 (en) Non-blooming gelatin and non-gelatin formulations
JP2000500504A (ja) Ｖｘ ４７８のようなｈｉｖプロテアーゼ阻害剤およびビタミンｅ―ｔｐｇｓのような水溶性ビタミンｅを含む組成物
WO2021016305A1 (en) Softshell capsule formulations, and methods of preparation and use thereof
HUP0100580A2 (hu) Oldott paroxetint tartalmazó készítmények
US20040146537A1 (en) Oily wax matrix suspension formulation comprising pharmacologically active agents
DK169566B1 (da) Flydende farmaceutisk præparat indeholdende en 4-aroyl-imidazol-2-on til anvendelse i doseringsformer til oral indgivelse samt fremgangsmåde til fremstilling af præparatet
JP2003504392A (ja) 新規医薬製剤
AU2014284294A1 (en) Capsule formulation comprising fexofenadine
JP2003510269A (ja) バソプレシン拮抗薬製剤および方法
JP2001513100A (ja) デクスフェンフルラミンのプログラムされた放出のための製薬学的組成物
CZ20001876A3 (cs) Prostředky obsahující rozpuštěný paroxetin

Legal Events

Date Code Title Description
RD04 Notification of resignation of power of attorney

Free format text: JAPANESE INTERMEDIATE CODE: A7424

Effective date: 20060517

RD02 Notification of acceptance of power of attorney

Free format text: JAPANESE INTERMEDIATE CODE: A7422

Effective date: 20060501

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20070831

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20070831

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20101130

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20110426